Document Detail

Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator.
MedLine Citation:
PMID:  15465079     Owner:  NLM     Status:  MEDLINE    
We hypothesized that pretreatment magnetic resonance imaging (MRI) parameters might predict clinical outcome, recanalization and final infarct size in acute ischemic stroke patients treated by intravenous recombinant tissue plasminogen activator (rt-PA). MRI was performed prior to thrombolysis and at day 1 with the following sequences: magnetic resonance angiography (MRA), T2*-gradient echo (GE) imaging, diffusion-weighted imaging (DWI) and perfusion-weighted imaging (PWI). Final infarct size was assessed at day 60 by T2-weighted imaging (T2-WI). The National Institutes of Health Stroke Scale (NIHSS) score was assessed prior to rt-PA therapy and the modified Rankin Scale (m-RS) score was assessed at day 60. A poor outcome was defined as a day 60 m-RS score >2. Univariate and multivariate logistic regression analyses were used to identify the predictors of clinical outcome, recanalization and infarct size. Forty-nine patients fulfilled the inclusion criteria. Baseline NIHSS score was the best independent indicator of clinical outcome (p=0.002). A worse clinical outcome was observed in patients with tandem internal carotid artery (ICA)+middle cerebral artery (MCA) occlusion versus other sites of arterial occlusion (p=0.009), and in patients with larger pretreatment PWI (p=0.001) and DWI (p=0.01) lesion volumes. Two factors predict a low rate of recanalization: a proximal site of arterial occlusion (p=0.02) and a delayed time to peak (TTP) on pretreatment PWI (p=0.05). The final infarct size was correlated with pretreatment DWI lesion volume (p=0.025). Recanalization was associated with a lower final infarct size (p=0.003). In conclusion, a severe baseline NIHSS score, a critical level of pretreatment DWI/PWI parameters and a proximal site of occlusion are predictive of a worse outcome after IV rt-PA for acute ischemic stroke.
Laurent Derex; Norbert Nighoghossian; Marc Hermier; Patrice Adeleine; Yves Berthezène; Frédéric Philippeau; Jérôme Honnorat; Jean-Claude Froment; Paul Trouillas
Related Documents :
16174909 - Technical refinements and drawbacks of a surface cooling technique for the treatment of...
1745339 - The biologic basis for the treatment of acute stroke.
19926989 - Reperfusion for acute ischemic stroke: arterial revascularization and collateral therap...
18597839 - Does differential prophylactic aspirin use contribute to racial and geographic disparit...
3838409 - Molsidomine in the treatment of acute heart failure.
8902919 - Late seizures following a first symptomatic brain infarct are related to large infarcts...
2886259 - Coronary ligation reduces maximum sustained swimming speed in chinook salmon, oncorhync...
2992259 - Technetium-99m-pyrophosphate scintigraphy in patients with suspected acute myocardial i...
18156139 - Non-invasive detection and quantification of acute myocardial infarction in rabbits usi...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  225     ISSN:  0022-510X     ISO Abbreviation:  J. Neurol. Sci.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2005-01-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  3-9     Citation Subset:  IM    
Service d'Urgences NeuroVasculaires, Hôpital Neurologique, 59 Boulevard Pinel, 69003 Lyon, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Analysis of Variance
Brain Infarction / diagnosis,  etiology*
Brain Mapping
Follow-Up Studies
Magnetic Resonance Imaging / methods
Middle Aged
Reproducibility of Results
Retrospective Studies
Stroke / complications,  diagnosis*,  drug therapy*
Time Factors
Tissue Plasminogen Activator / therapeutic use*
Tomography, X-Ray Computed / methods
Trauma Severity Indices
Treatment Outcome
Reg. No./Substance:
EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Psychometric study of quality of life instruments used during hospitalization for stem cell transpla...
Next Document:  Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and...